Boyle M J, Baghdassarian V, Stepkowski S M, Dumble L J, Kahan B D
Department of Surgery, The University of Texas Medical School at Houston, 77030, USA.
Cell Transplant. 1998 May-Jun;7(3):247-56. doi: 10.1177/096368979800700303.
These experiments investigated the immunosuppressive properties of liver tissue. Brown Norway (BN; RT1n) rat heart allografts survived in untreated control Wistar Furth (WFu; RTl(u)) rat recipients for 6.2 +/- 1.5 days, while allografts in animals that received rapamycin (RAPA) 0.0075 mg/kg/day and cyclosporine (CsA) 0.375 mg/kg/day delivered for 14 days by continuous intravenous infusion (civi) using osmotic pumps in conjunction with intrasplenic (i.s.) saline survived to 18.4 +/- 1.3 days. i.s. addition of 3 M-KCl extracted BN hepatic antigen or unpurified BN hepatocytes (liver parenchymal cells-5 x 10(7)/kg), which exhibited a 4.8% class II antigen expression, and which alone failed to prolong allograft survival (MST = 6.0 +/- 1.4 days), increased heart allograft survival to 25.3 +/- 2.3 and 27.2 +/- 1.9 days, respectively (p < 0.01). Hepatocyte purification using Dynabeads and Percoll reduced class II expression to 0.9% and increased allograft survival to 32.8 +/- 1.6 days (p < 0.01). In contrast, the effect of 5 x 10(8)/kg BN erythrocytes, exhibiting only 0.1% class II expression, was much less (23.8 +/- 1.9 days). Administration i.s. of BN splenocytes or nonparenchymal liver cells, demonstrated by flow cytometry to exhibit a 47.3 or 55.1% expression of class II antigen, respectively, failed to induce any significant increase in allograft survival (18.4 +/- 4.6 and 19.4 +/- 0.5 days, respectively). Survival of BN rat small bowel allografts was increased in Lewis (LEW; RTl1) rat recipients treated with RAPA, CsA, and unfractionated BN hepatocytes from 10.2 +/- 1.9 to 21.2 +/- 1.5 days. Pretreatment with i.s. BN hepatocytes, 14 days prior to harvesting, reduced WFu lymphocyte responses to allogeneic stimulation with BN or ACI spleen cells by 75 and 70%, respectively. Addition of 1 x 10(5) unpurified donor-specific BN or third-party Buffalo (BUF; RTl(b)) hepatocytes, but not supernatant, to the responder wells of MLCs resulted in a 61 and 40% suppression, respectively, of the WFu lymphocyte response induced by BN allogeneic stimulation. These findings suggest that while class I MHC expression has a significant role to play in exerting the immunosuppressive effects of hepatocytes, other influences more specific to liver may also prevail.
这些实验研究了肝组织的免疫抑制特性。在未经处理的对照Wistar Furth(WFu;RTl(u))大鼠受体中,棕色挪威(BN;RT1n)大鼠心脏同种异体移植物存活6.2±1.5天,而通过渗透泵连续静脉输注(civi)联合脾内(i.s.)注射生理盐水给予0.0075 mg/kg/天雷帕霉素(RAPA)和0.375 mg/kg/天环孢素(CsA)14天的动物的同种异体移植物存活至18.4±1.3天。脾内添加3 M - KCl提取的BN肝抗原或未纯化的BN肝细胞(肝实质细胞 - 5×10⁷/kg),其II类抗原表达为4.8%,单独使用时未能延长同种异体移植物存活时间(平均存活时间 = 6.0±1.4天),但分别将心脏同种异体移植物存活时间延长至25.3±2.3天和27.2±1.9天(p < 0.01)。使用磁珠和 Percoll 进行肝细胞纯化可将II类表达降低至0.9%,并将同种异体移植物存活时间延长至32.8±1.6天(p < 0.01)。相比之下,5×10⁸/kg BN红细胞(仅表现出0.1%的II类表达)的作用要小得多(23.8±1.9天)。脾内注射BN脾细胞或非实质肝细胞,通过流式细胞术检测分别显示II类抗原表达为47.3%或55.1%,但均未能显著延长同种异体移植物存活时间(分别为(18.4±4.6天和19.4±0.5天)。在用RAPA、CsA和未分级的BN肝细胞治疗的Lewis(LEW;RTl1)大鼠受体中,BN大鼠小肠同种异体移植物的存活时间从10.2±1.9天增加到21.2±1.5天。在收获前14天用脾内注射BN肝细胞进行预处理,可使WFu淋巴细胞对BN或ACI脾细胞的同种异体刺激反应分别降低75%和70%。在混合淋巴细胞培养(MLC)的反应孔中添加1×10⁵未纯化的供体特异性BN或第三方布法罗(BUF;RTl(b))肝细胞(而非上清液),分别导致WFu淋巴细胞对BN同种异体刺激诱导的反应抑制61%和40%。这些发现表明,虽然I类MHC表达在发挥肝细胞的免疫抑制作用中起重要作用,但肝脏更具特异性的其他影响因素可能也占主导地位。